nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0264	0.0352	CbGbCtD
Thioridazine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.026	0.0347	CbGbCtD
Thioridazine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.026	0.0347	CbGbCtD
Thioridazine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0257	0.0343	CbGbCtD
Thioridazine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0241	0.0322	CbGbCtD
Thioridazine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0237	0.0316	CbGbCtD
Thioridazine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0223	0.0297	CbGbCtD
Thioridazine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0223	0.0297	CbGbCtD
Thioridazine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0218	0.0291	CbGbCtD
Thioridazine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0218	0.0291	CbGbCtD
Thioridazine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0213	0.0285	CbGbCtD
Thioridazine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0201	0.0269	CbGbCtD
Thioridazine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0201	0.0268	CbGbCtD
Thioridazine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0201	0.0268	CbGbCtD
Thioridazine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0197	0.0263	CbGbCtD
Thioridazine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0197	0.0263	CbGbCtD
Thioridazine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0195	0.0261	CbGbCtD
Thioridazine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0189	0.0252	CbGbCtD
Thioridazine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0188	0.0252	CbGbCtD
Thioridazine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0184	0.0245	CbGbCtD
Thioridazine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0184	0.0245	CbGbCtD
Thioridazine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0183	0.0244	CbGbCtD
Thioridazine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0182	0.0242	CbGbCtD
Thioridazine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0182	0.0242	CbGbCtD
Thioridazine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0169	0.0225	CbGbCtD
Thioridazine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0166	0.0222	CbGbCtD
Thioridazine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0166	0.0222	CbGbCtD
Thioridazine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0165	0.0221	CbGbCtD
Thioridazine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0165	0.0221	CbGbCtD
Thioridazine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0159	0.0212	CbGbCtD
Thioridazine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0157	0.0209	CbGbCtD
Thioridazine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0153	0.0204	CbGbCtD
Thioridazine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0152	0.0203	CbGbCtD
Thioridazine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0143	0.0191	CbGbCtD
Thioridazine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0139	0.0186	CbGbCtD
Thioridazine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0138	0.0184	CbGbCtD
Thioridazine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0138	0.0184	CbGbCtD
Thioridazine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0132	0.0176	CbGbCtD
Thioridazine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0126	0.0168	CbGbCtD
Thioridazine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0126	0.0168	CbGbCtD
Thioridazine—DRD1—nerve—acquired immunodeficiency syndrome	0.00289	0.0498	CbGeAlD
Thioridazine—HTR7—nerve—acquired immunodeficiency syndrome	0.00181	0.0311	CbGeAlD
Thioridazine—DRD2—nerve—acquired immunodeficiency syndrome	0.00171	0.0294	CbGeAlD
Thioridazine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00154	0.0265	CbGeAlD
Thioridazine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0246	CbGeAlD
Thioridazine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00137	0.0235	CbGeAlD
Thioridazine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00133	0.023	CbGeAlD
Thioridazine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00116	0.0201	CbGeAlD
Thioridazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00113	0.0194	CbGeAlD
Thioridazine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00109	0.0188	CbGeAlD
Thioridazine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0178	CbGeAlD
Thioridazine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.001	0.0173	CbGeAlD
Thioridazine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00098	0.0169	CbGeAlD
Thioridazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000959	0.0165	CbGeAlD
Thioridazine—HTR6—nervous system—acquired immunodeficiency syndrome	0.000874	0.0151	CbGeAlD
Thioridazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000852	0.0147	CbGeAlD
Thioridazine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000841	0.0145	CbGeAlD
Thioridazine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000776	0.0134	CbGeAlD
Thioridazine—DRD2—retina—acquired immunodeficiency syndrome	0.000707	0.0122	CbGeAlD
Thioridazine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000697	0.012	CbGeAlD
Thioridazine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000671	0.0116	CbGeAlD
Thioridazine—HTR6—brain—acquired immunodeficiency syndrome	0.000668	0.0115	CbGeAlD
Thioridazine—DRD1—nervous system—acquired immunodeficiency syndrome	0.00065	0.0112	CbGeAlD
Thioridazine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000626	0.0108	CbGeAlD
Thioridazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000599	0.0103	CbGeAlD
Thioridazine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000533	0.00918	CbGeAlD
Thioridazine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000525	0.00905	CbGeAlD
Thioridazine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000524	0.00903	CbGeAlD
Thioridazine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000513	0.00884	CbGeAlD
Thioridazine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000513	0.00884	CbGeAlD
Thioridazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000505	0.0087	CbGeAlD
Thioridazine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000504	0.00869	CbGeAlD
Thioridazine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000504	0.00869	CbGeAlD
Thioridazine—HTR7—blood—acquired immunodeficiency syndrome	0.0005	0.00862	CbGeAlD
Thioridazine—DRD1—brain—acquired immunodeficiency syndrome	0.000497	0.00856	CbGeAlD
Thioridazine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000489	0.00842	CbGeAlD
Thioridazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000486	0.00838	CbGeAlD
Thioridazine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000483	0.00832	CbGeAlD
Thioridazine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000482	0.00831	CbGeAlD
Thioridazine—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000471	0.00301	CcSEcCtD
Thioridazine—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000469	0.003	CcSEcCtD
Thioridazine—HTR2A—retina—acquired immunodeficiency syndrome	0.000466	0.00804	CbGeAlD
Thioridazine—KCNH2—blood—acquired immunodeficiency syndrome	0.000466	0.00803	CbGeAlD
Thioridazine—Mental disorder—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.00298	CcSEcCtD
Thioridazine—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000462	0.00296	CcSEcCtD
Thioridazine—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.000461	0.00295	CcSEcCtD
Thioridazine—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.00046	0.00294	CcSEcCtD
Thioridazine—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000453	0.0029	CcSEcCtD
Thioridazine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000453	0.0078	CbGeAlD
Thioridazine—Weight increased—Saquinavir—acquired immunodeficiency syndrome	0.000452	0.00289	CcSEcCtD
Thioridazine—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000451	0.00777	CbGeAlD
Thioridazine—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.00288	CcSEcCtD
Thioridazine—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000449	0.00288	CcSEcCtD
Thioridazine—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000449	0.00774	CbGeAlD
Thioridazine—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.000448	0.00287	CcSEcCtD
Thioridazine—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00044	0.00282	CcSEcCtD
Thioridazine—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.00281	CcSEcCtD
Thioridazine—HTR7—lung—acquired immunodeficiency syndrome	0.000439	0.00756	CbGeAlD
Thioridazine—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00279	CcSEcCtD
Thioridazine—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000434	0.00278	CcSEcCtD
Thioridazine—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.000433	0.00277	CcSEcCtD
Thioridazine—KCNH2—vagina—acquired immunodeficiency syndrome	0.000432	0.00744	CbGeAlD
Thioridazine—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.000431	0.00276	CcSEcCtD
Thioridazine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000428	0.00274	CcSEcCtD
Thioridazine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.000427	0.00274	CcSEcCtD
Thioridazine—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000427	0.00273	CcSEcCtD
Thioridazine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000427	0.00735	CbGeAlD
Thioridazine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000426	0.00273	CcSEcCtD
Thioridazine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000425	0.00732	CbGeAlD
Thioridazine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00272	CcSEcCtD
Thioridazine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000422	0.0027	CcSEcCtD
Thioridazine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000421	0.00269	CcSEcCtD
Thioridazine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000419	0.00269	CcSEcCtD
Thioridazine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000419	0.00722	CbGeAlD
Thioridazine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000419	0.00268	CcSEcCtD
Thioridazine—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.000417	0.00267	CcSEcCtD
Thioridazine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000415	0.00266	CcSEcCtD
Thioridazine—DRD2—lung—acquired immunodeficiency syndrome	0.000415	0.00715	CbGeAlD
Thioridazine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000414	0.00265	CcSEcCtD
Thioridazine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000414	0.00265	CcSEcCtD
Thioridazine—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.000411	0.00263	CcSEcCtD
Thioridazine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000409	0.00705	CbGeAlD
Thioridazine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000407	0.00261	CcSEcCtD
Thioridazine—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.0026	CcSEcCtD
Thioridazine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000406	0.007	CbGeAlD
Thioridazine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000406	0.0026	CcSEcCtD
Thioridazine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000405	0.00259	CcSEcCtD
Thioridazine—Tremor—Indinavir—acquired immunodeficiency syndrome	0.000403	0.00258	CcSEcCtD
Thioridazine—CHRM2—brain—acquired immunodeficiency syndrome	0.0004	0.0069	CbGeAlD
Thioridazine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.0004	0.00256	CcSEcCtD
Thioridazine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000399	0.00256	CcSEcCtD
Thioridazine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000399	0.00688	CbGeAlD
Thioridazine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000398	0.00685	CbGeAlD
Thioridazine—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000397	0.00254	CcSEcCtD
Thioridazine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000395	0.00681	CbGeAlD
Thioridazine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000395	0.00253	CcSEcCtD
Thioridazine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000395	0.00253	CcSEcCtD
Thioridazine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000394	0.00252	CcSEcCtD
Thioridazine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00251	CcSEcCtD
Thioridazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000392	0.00676	CbGeAlD
Thioridazine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000392	0.00675	CbGeAlD
Thioridazine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000391	0.00674	CbGeAlD
Thioridazine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000391	0.0025	CcSEcCtD
Thioridazine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000389	0.00249	CcSEcCtD
Thioridazine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000387	0.00248	CcSEcCtD
Thioridazine—HTR2C—brain—acquired immunodeficiency syndrome	0.000386	0.00665	CbGeAlD
Thioridazine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000386	0.00247	CcSEcCtD
Thioridazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000384	0.00662	CbGeAlD
Thioridazine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00245	CcSEcCtD
Thioridazine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000382	0.00657	CbGeAlD
Thioridazine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00038	0.00244	CcSEcCtD
Thioridazine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00038	0.00243	CcSEcCtD
Thioridazine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000379	0.00653	CbGeAlD
Thioridazine—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000378	0.00652	CbGeAlD
Thioridazine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000378	0.00242	CcSEcCtD
Thioridazine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000377	0.0065	CbGeAlD
Thioridazine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000377	0.00241	CcSEcCtD
Thioridazine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00241	CcSEcCtD
Thioridazine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000377	0.00649	CbGeAlD
Thioridazine—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000375	0.0024	CcSEcCtD
Thioridazine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000375	0.0024	CcSEcCtD
Thioridazine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000373	0.00239	CcSEcCtD
Thioridazine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000372	0.00238	CcSEcCtD
Thioridazine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000371	0.00238	CcSEcCtD
Thioridazine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000371	0.00237	CcSEcCtD
Thioridazine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00037	0.00237	CcSEcCtD
Thioridazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00037	0.00637	CbGeAlD
Thioridazine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.00236	CcSEcCtD
Thioridazine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000368	0.00236	CcSEcCtD
Thioridazine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000367	0.00632	CbGeAlD
Thioridazine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.00234	CcSEcCtD
Thioridazine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000365	0.00233	CcSEcCtD
Thioridazine—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000364	0.00628	CbGeAlD
Thioridazine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000364	0.00233	CcSEcCtD
Thioridazine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.00231	CcSEcCtD
Thioridazine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.0023	CcSEcCtD
Thioridazine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000359	0.0023	CcSEcCtD
Thioridazine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000359	0.00619	CbGeAlD
Thioridazine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000359	0.0023	CcSEcCtD
Thioridazine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000357	0.00229	CcSEcCtD
Thioridazine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000355	0.00227	CcSEcCtD
Thioridazine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000355	0.00227	CcSEcCtD
Thioridazine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000354	0.00609	CbGeAlD
Thioridazine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00225	CcSEcCtD
Thioridazine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00225	CcSEcCtD
Thioridazine—CYP1A2—lung—acquired immunodeficiency syndrome	0.00035	0.00603	CbGeAlD
Thioridazine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000349	0.00223	CcSEcCtD
Thioridazine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00223	CcSEcCtD
Thioridazine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00223	CcSEcCtD
Thioridazine—HRH1—vagina—acquired immunodeficiency syndrome	0.000346	0.00597	CbGeAlD
Thioridazine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000346	0.00596	CbGeAlD
Thioridazine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000346	0.00221	CcSEcCtD
Thioridazine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000346	0.00221	CcSEcCtD
Thioridazine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000345	0.00221	CcSEcCtD
Thioridazine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.0022	CcSEcCtD
Thioridazine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000343	0.0022	CcSEcCtD
Thioridazine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000343	0.0022	CcSEcCtD
Thioridazine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000343	0.0022	CcSEcCtD
Thioridazine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000342	0.00219	CcSEcCtD
Thioridazine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00034	0.00586	CbGeAlD
Thioridazine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000339	0.00217	CcSEcCtD
Thioridazine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00217	CcSEcCtD
Thioridazine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000338	0.00216	CcSEcCtD
Thioridazine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00215	CcSEcCtD
Thioridazine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00215	CcSEcCtD
Thioridazine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000334	0.00214	CcSEcCtD
Thioridazine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.00214	CcSEcCtD
Thioridazine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.00213	CcSEcCtD
Thioridazine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000331	0.00212	CcSEcCtD
Thioridazine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.00211	CcSEcCtD
Thioridazine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.00211	CcSEcCtD
Thioridazine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000328	0.0021	CcSEcCtD
Thioridazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000328	0.00564	CbGeAlD
Thioridazine—HRH1—lung—acquired immunodeficiency syndrome	0.000328	0.00564	CbGeAlD
Thioridazine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000326	0.00208	CcSEcCtD
Thioridazine—HTR1A—brain—acquired immunodeficiency syndrome	0.000325	0.0056	CbGeAlD
Thioridazine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00208	CcSEcCtD
Thioridazine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.00207	CcSEcCtD
Thioridazine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.00207	CcSEcCtD
Thioridazine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000323	0.00206	CcSEcCtD
Thioridazine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000322	0.00554	CbGeAlD
Thioridazine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00206	CcSEcCtD
Thioridazine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.00205	CcSEcCtD
Thioridazine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00205	CcSEcCtD
Thioridazine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.00205	CcSEcCtD
Thioridazine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00032	0.00205	CcSEcCtD
Thioridazine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00205	CcSEcCtD
Thioridazine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000318	0.00203	CcSEcCtD
Thioridazine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00203	CcSEcCtD
Thioridazine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00203	CcSEcCtD
Thioridazine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.00202	CcSEcCtD
Thioridazine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000315	0.00202	CcSEcCtD
Thioridazine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000315	0.00202	CcSEcCtD
Thioridazine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000315	0.00202	CcSEcCtD
Thioridazine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000315	0.00542	CbGeAlD
Thioridazine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000313	0.002	CcSEcCtD
Thioridazine—HTR2A—blood—acquired immunodeficiency syndrome	0.000312	0.00538	CbGeAlD
Thioridazine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000312	0.002	CcSEcCtD
Thioridazine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00199	CcSEcCtD
Thioridazine—HTR7—brain—acquired immunodeficiency syndrome	0.000311	0.00535	CbGeAlD
Thioridazine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00199	CcSEcCtD
Thioridazine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00198	CcSEcCtD
Thioridazine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.00198	CcSEcCtD
Thioridazine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.00198	CcSEcCtD
Thioridazine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000307	0.00197	CcSEcCtD
Thioridazine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000307	0.00196	CcSEcCtD
Thioridazine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000305	0.00195	CcSEcCtD
Thioridazine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00195	CcSEcCtD
Thioridazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000303	0.00523	CbGeAlD
Thioridazine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00193	CcSEcCtD
Thioridazine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.00193	CcSEcCtD
Thioridazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000301	0.00518	CbGeAlD
Thioridazine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.0003	0.00192	CcSEcCtD
Thioridazine—ADRA1A—brain—acquired immunodeficiency syndrome	0.0003	0.00516	CbGeAlD
Thioridazine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000298	0.00514	CbGeAlD
Thioridazine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00191	CcSEcCtD
Thioridazine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000298	0.00513	CbGeAlD
Thioridazine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000298	0.00191	CcSEcCtD
Thioridazine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000297	0.0019	CcSEcCtD
Thioridazine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000297	0.0019	CcSEcCtD
Thioridazine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000296	0.0019	CcSEcCtD
Thioridazine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.00189	CcSEcCtD
Thioridazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00189	CcSEcCtD
Thioridazine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00189	CcSEcCtD
Thioridazine—DRD2—brain—acquired immunodeficiency syndrome	0.000294	0.00506	CbGeAlD
Thioridazine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00188	CcSEcCtD
Thioridazine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000292	0.00187	CcSEcCtD
Thioridazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000292	0.00503	CbGeAlD
Thioridazine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000291	0.00502	CbGeAlD
Thioridazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000289	0.00498	CbGeAlD
Thioridazine—KCNH2—brain—acquired immunodeficiency syndrome	0.000289	0.00498	CbGeAlD
Thioridazine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00185	CcSEcCtD
Thioridazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00184	CcSEcCtD
Thioridazine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00184	CcSEcCtD
Thioridazine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000287	0.00494	CbGeAlD
Thioridazine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00183	CcSEcCtD
Thioridazine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000286	0.00183	CcSEcCtD
Thioridazine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.00182	CcSEcCtD
Thioridazine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000284	0.0049	CbGeAlD
Thioridazine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00181	CcSEcCtD
Thioridazine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00181	CcSEcCtD
Thioridazine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000283	0.00181	CcSEcCtD
Thioridazine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000283	0.00181	CcSEcCtD
Thioridazine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00181	CcSEcCtD
Thioridazine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.0018	CcSEcCtD
Thioridazine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000282	0.0018	CcSEcCtD
Thioridazine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000281	0.00483	CbGeAlD
Thioridazine—KCNH2—lymph node—acquired immunodeficiency syndrome	0.00028	0.00482	CbGeAlD
Thioridazine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.00179	CcSEcCtD
Thioridazine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00177	CcSEcCtD
Thioridazine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000277	0.00177	CcSEcCtD
Thioridazine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00177	CcSEcCtD
Thioridazine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000276	0.00177	CcSEcCtD
Thioridazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.00176	CcSEcCtD
Thioridazine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.00176	CcSEcCtD
Thioridazine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.00176	CcSEcCtD
Thioridazine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00175	CcSEcCtD
Thioridazine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000274	0.00175	CcSEcCtD
Thioridazine—HTR2A—lung—acquired immunodeficiency syndrome	0.000274	0.00471	CbGeAlD
Thioridazine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000273	0.00175	CcSEcCtD
Thioridazine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00175	CcSEcCtD
Thioridazine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.00175	CcSEcCtD
Thioridazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000273	0.00175	CcSEcCtD
Thioridazine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000272	0.00174	CcSEcCtD
Thioridazine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000272	0.00174	CcSEcCtD
Thioridazine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00174	CcSEcCtD
Thioridazine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00174	CcSEcCtD
Thioridazine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00027	0.00173	CcSEcCtD
Thioridazine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000269	0.00172	CcSEcCtD
Thioridazine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00172	CcSEcCtD
Thioridazine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00172	CcSEcCtD
Thioridazine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000268	0.00171	CcSEcCtD
Thioridazine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000267	0.00171	CcSEcCtD
Thioridazine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000265	0.00456	CbGeAlD
Thioridazine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.00169	CcSEcCtD
Thioridazine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00169	CcSEcCtD
Thioridazine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00168	CcSEcCtD
Thioridazine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00167	CcSEcCtD
Thioridazine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00167	CcSEcCtD
Thioridazine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.00167	CcSEcCtD
Thioridazine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00165	CcSEcCtD
Thioridazine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000258	0.00165	CcSEcCtD
Thioridazine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00165	CcSEcCtD
Thioridazine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00165	CcSEcCtD
Thioridazine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00164	CcSEcCtD
Thioridazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00163	CcSEcCtD
Thioridazine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00163	CcSEcCtD
Thioridazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000253	0.00436	CbGeAlD
Thioridazine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00161	CcSEcCtD
Thioridazine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00161	CcSEcCtD
Thioridazine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.00161	CcSEcCtD
Thioridazine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.0016	CcSEcCtD
Thioridazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00157	CcSEcCtD
Thioridazine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.00156	CcSEcCtD
Thioridazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000244	0.0042	CbGeAlD
Thioridazine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00155	CcSEcCtD
Thioridazine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00154	CcSEcCtD
Thioridazine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00024	0.00154	CcSEcCtD
Thioridazine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00153	CcSEcCtD
Thioridazine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00153	CcSEcCtD
Thioridazine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.00152	CcSEcCtD
Thioridazine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.00152	CcSEcCtD
Thioridazine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00151	CcSEcCtD
Thioridazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.0015	CcSEcCtD
Thioridazine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.0015	CcSEcCtD
Thioridazine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00149	CcSEcCtD
Thioridazine—HRH1—brain—acquired immunodeficiency syndrome	0.000232	0.00399	CbGeAlD
Thioridazine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00148	CcSEcCtD
Thioridazine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000231	0.00398	CbGeAlD
Thioridazine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00147	CcSEcCtD
Thioridazine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000228	0.00392	CbGeAlD
Thioridazine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.00145	CcSEcCtD
Thioridazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000224	0.00386	CbGeAlD
Thioridazine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00143	CcSEcCtD
Thioridazine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00143	CcSEcCtD
Thioridazine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00143	CcSEcCtD
Thioridazine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000223	0.00384	CbGeAlD
Thioridazine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000222	0.00383	CbGeAlD
Thioridazine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00142	CcSEcCtD
Thioridazine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00142	CcSEcCtD
Thioridazine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00141	CcSEcCtD
Thioridazine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00022	0.00379	CbGeAlD
Thioridazine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00141	CcSEcCtD
Thioridazine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.00139	CcSEcCtD
Thioridazine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00138	CcSEcCtD
Thioridazine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00136	CcSEcCtD
Thioridazine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00135	CcSEcCtD
Thioridazine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00134	CcSEcCtD
Thioridazine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00134	CcSEcCtD
Thioridazine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000208	0.00133	CcSEcCtD
Thioridazine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00133	CcSEcCtD
Thioridazine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00133	CcSEcCtD
Thioridazine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00129	CcSEcCtD
Thioridazine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00128	CcSEcCtD
Thioridazine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00128	CcSEcCtD
Thioridazine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00128	CcSEcCtD
Thioridazine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.00127	CcSEcCtD
Thioridazine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00127	CcSEcCtD
Thioridazine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00126	CcSEcCtD
Thioridazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000194	0.00334	CbGeAlD
Thioridazine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.00124	CcSEcCtD
Thioridazine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.00121	CcSEcCtD
Thioridazine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00119	CcSEcCtD
Thioridazine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00118	CcSEcCtD
Thioridazine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00118	CcSEcCtD
Thioridazine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00118	CcSEcCtD
Thioridazine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00118	CcSEcCtD
Thioridazine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00115	CcSEcCtD
Thioridazine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00114	CcSEcCtD
Thioridazine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00114	CcSEcCtD
Thioridazine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.00113	CcSEcCtD
Thioridazine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000176	0.00304	CbGeAlD
Thioridazine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00111	CcSEcCtD
Thioridazine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.0011	CcSEcCtD
Thioridazine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00109	CcSEcCtD
Thioridazine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00109	CcSEcCtD
Thioridazine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.00108	CcSEcCtD
Thioridazine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00107	CcSEcCtD
Thioridazine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00102	CcSEcCtD
Thioridazine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000105	0.193	CrCbGaD
Thioridazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.000103	0.189	CrCbGaD
Thioridazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	0.000101	0.186	CrCbGaD
Thioridazine—Thiothixene—ALB—acquired immunodeficiency syndrome	0.000101	0.186	CrCbGaD
Thioridazine—Clomipramine—ALB—acquired immunodeficiency syndrome	8e-05	0.147	CrCbGaD
Thioridazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	5.49e-05	0.101	CrCbGaD
Thioridazine—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.000645	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.31e-05	0.000643	CbGpPWpGaD
Thioridazine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.31e-05	0.000642	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.29e-05	0.000638	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.27e-05	0.000633	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.27e-05	0.000632	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.27e-05	0.000632	CbGpPWpGaD
Thioridazine—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000631	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.26e-05	0.000628	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.25e-05	0.000628	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.25e-05	0.000628	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.25e-05	0.000628	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.25e-05	0.000627	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.24e-05	0.000623	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.22e-05	0.000619	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.22e-05	0.000619	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.22e-05	0.000618	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.22e-05	0.000618	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.22e-05	0.000617	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.21e-05	0.000616	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.21e-05	0.000616	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.21e-05	0.000616	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.21e-05	0.000615	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.2e-05	0.000614	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	2.19e-05	0.000611	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.18e-05	0.000607	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.000606	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.000606	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.18e-05	0.000606	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.000605	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.000605	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.15e-05	0.000599	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.15e-05	0.000598	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.14e-05	0.000596	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.12e-05	0.00059	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.11e-05	0.000587	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.07e-05	0.000578	CbGpPWpGaD
Thioridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000572	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.05e-05	0.000571	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.05e-05	0.000571	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.05e-05	0.000571	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.05e-05	0.00057	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.05e-05	0.00057	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.05e-05	0.00057	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.05e-05	0.00057	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.02e-05	0.000562	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.02e-05	0.000562	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.02e-05	0.000562	CbGpPWpGaD
Thioridazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.97e-05	0.000548	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.95e-05	0.000544	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.94e-05	0.000541	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.94e-05	0.00054	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.93e-05	0.000537	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.92e-05	0.000536	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000533	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.91e-05	0.000533	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.89e-05	0.000526	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.88e-05	0.000522	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.87e-05	0.000522	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.86e-05	0.000518	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.86e-05	0.000518	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.86e-05	0.000517	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.85e-05	0.000516	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.85e-05	0.000514	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.00051	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.00051	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.000509	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.000508	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.000507	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.0005	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.000499	CbGpPWpGaD
Thioridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.78e-05	0.000497	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.78e-05	0.000497	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.78e-05	0.000496	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.77e-05	0.000494	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.76e-05	0.000491	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.76e-05	0.000491	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.76e-05	0.00049	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.75e-05	0.000488	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.75e-05	0.000486	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.72e-05	0.000478	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.72e-05	0.000478	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.7e-05	0.000474	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.7e-05	0.000473	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.69e-05	0.000471	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.69e-05	0.00047	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.69e-05	0.00047	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.68e-05	0.000469	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000467	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.000466	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.000465	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.67e-05	0.000464	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.000463	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.000462	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.000461	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.00046	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000458	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000456	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000454	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000453	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.61e-05	0.000449	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.61e-05	0.000447	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.57e-05	0.000436	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.56e-05	0.000434	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.56e-05	0.000434	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.55e-05	0.00043	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.54e-05	0.000429	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.54e-05	0.000428	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.54e-05	0.000428	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.54e-05	0.000428	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.54e-05	0.000428	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000427	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000424	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000423	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000422	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.52e-05	0.000422	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.52e-05	0.000422	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.51e-05	0.000421	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000421	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.51e-05	0.000421	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000421	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.51e-05	0.00042	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.51e-05	0.00042	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.51e-05	0.00042	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000416	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000415	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.44e-05	0.000402	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.44e-05	0.000402	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.42e-05	0.000394	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000391	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000391	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.4e-05	0.00039	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.39e-05	0.000388	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.39e-05	0.000388	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.39e-05	0.000387	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000385	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000382	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000382	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.000381	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.36e-05	0.00038	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.34e-05	0.000374	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.33e-05	0.000371	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.33e-05	0.000371	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.32e-05	0.000368	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.31e-05	0.000365	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.31e-05	0.000365	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.31e-05	0.000364	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.31e-05	0.000364	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000363	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.000358	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000358	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.28e-05	0.000357	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.28e-05	0.000357	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.27e-05	0.000353	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.24e-05	0.000346	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000337	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.19e-05	0.000332	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.19e-05	0.000332	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.18e-05	0.000329	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.15e-05	0.000321	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.15e-05	0.00032	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000317	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000315	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000312	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.11e-05	0.00031	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.11e-05	0.000308	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.1e-05	0.000306	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.000301	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000297	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.04e-05	0.000289	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000288	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000283	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.01e-05	0.000282	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000282	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.01e-05	0.000281	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.98e-06	0.000278	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.97e-06	0.000278	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.95e-06	0.000277	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.9e-06	0.000276	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.83e-06	0.000274	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.82e-06	0.000273	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.8e-06	0.000273	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.79e-06	0.000273	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.76e-06	0.000272	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.68e-06	0.00027	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.67e-06	0.000269	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.65e-06	0.000269	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.64e-06	0.000268	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.62e-06	0.000268	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.5e-06	0.000264	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.47e-06	0.000264	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.13e-06	0.000254	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.07e-06	0.000253	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.98e-06	0.00025	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.96e-06	0.00025	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.93e-06	0.000249	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.93e-06	0.000249	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.82e-06	0.000246	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.8e-06	0.000245	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.8e-06	0.000245	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.79e-06	0.000245	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.77e-06	0.000244	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.63e-06	0.00024	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.63e-06	0.00024	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.6e-06	0.00024	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.17e-06	0.000228	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.12e-06	0.000226	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.11e-06	0.000226	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.08e-06	0.000225	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.07e-06	0.000225	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.99e-06	0.000223	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.99e-06	0.000195	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	6.96e-06	0.000194	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.95e-06	0.000194	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	6.39e-06	0.000178	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.01e-06	0.000167	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.98e-06	0.000166	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.98e-06	0.000166	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.95e-06	0.000166	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.72e-06	0.000159	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.69e-06	0.000158	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	5.53e-06	0.000154	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.27e-06	0.000147	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.25e-06	0.000146	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.19e-06	0.000144	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.18e-06	0.000144	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.16e-06	0.000144	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.15e-06	0.000143	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.1e-06	0.000142	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.08e-06	0.000141	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.07e-06	0.000141	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.06e-06	0.000141	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.93e-06	0.000137	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.77e-06	0.000133	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.77e-06	0.000133	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.72e-06	0.000131	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.7e-06	0.000131	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.54e-06	0.000126	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.5e-06	0.000125	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.11e-06	0.000114	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.84e-06	0.000107	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.53e-06	9.83e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.51e-06	9.78e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.36e-06	9.36e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.1e-06	8.63e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.05e-06	8.49e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.04e-06	8.47e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3e-06	8.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.99e-06	8.32e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.78e-06	7.73e-05	CbGpPWpGaD
